16 results
10-Q
2023 Q3
EX-3.1
TRML
Tourmaline Bio Inc
Quarterly report
14 Nov 23
5:12pm
8-K
EX-3.3
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.1
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-3.2
TRML
Tourmaline Bio Inc
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
S-4
EX-3.2
TRML
Tourmaline Bio Inc
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.3
p7oqyv5q5piwvtvo5
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-3.1
tw1 ua6n3b2ccx39klbp
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
8-K
EX-3.2
q81 g19hz8k3zubh
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
EX-3.1
e5j9kdw68uvrt5o
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
S-1/A
EX-3.2
0nht26wz7gj79
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.1
2unkxrb v2xo74
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
ph4jtxj3l0q 5f
3 May 21
IPO registration (amended)
6:07am
S-1
EX-3.1
46u2vg9
16 Apr 21
IPO registration
5:03pm
S-1
EX-3.3
29dpw403pa0xu80y
16 Apr 21
IPO registration
5:03pm
DRS
EX-3.1
bcfbvk18o
26 Feb 21
Draft registration statement
12:00am
DRS
EX-3.3
s51uajwnim5 6o
26 Feb 21
Draft registration statement
12:00am
- Prev
- 1
- Next